2Robert D,Lott JA,Nolte FS,et al.Diagnosis and monitoring of hepatic Injury.I.Performance Characteristics of Laboratory Tests[J].Climical Chemistry,2000,46(3):2027.
二级参考文献16
1林其燧 文庆成.临床化学诊断方法大全[M].北京:北京大学出版社,1990.488.
2Goncales FL, Stucchi RS, Papaiordanou PM,et al. Elevated alanine aminotransferase (ALT) in blood donors: an assessment of the main associated conditions and its relationship to the development of hepatitis C. Rev Inst Med Trop SaoPaulo,1998,40(4) :219
3Ramesh V, Saraswat S, Choudhury N,et al. Relationship of serum alanine aminotransferase (ALT) to body mass index (BMI) in blood donors: the need to correct ALT for BMI in blood donor screening. Transfus Med, 1995,5 (4): 273
4Piton A, Poynard T, Imbert Bismut F,et al. Factors associated with serum alanine transaminase activity in healthy subjects:consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C.Hepatolog
5Cable R, Badon S, Pray C,et al. Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors. Transfusion, 1997, 37(2): 206
6Leclercq I, Horsmans Y, Bruyere M,et al. Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors. Acta Gastroenterol Belg,1999,62(1) :16
7Lozano M, Cid J, Bedini JL, et al. Study of serum alanine aminotransferase levels in blood donors in Spain. Haematologica,1998,83(3):237
8Van der Poel C,Noel L,Barbara J,et al. ISBA working party on transmissible diseases:report on the workshop infections diseas testing and quality control. Vox Sang,1996,70(1):53
9Grunenberg R, Banik N, Kruger J. Alanine aminotransferase (ALAT, GPT) : a reevaluation of exclusion limits for blood donors. Infusionsther Transfusionsmed, 1995,22(3):142
10Robert D, Lott JA, Nolte FS, et al. Diagnosis and monitoring of hepatic Injury. I. Performance Characteristics of Laboratory Tests. Clinical Chemistry, 2000, 46: 2027
5Schindhelm RK, Diamant M,Dekker JM, et al. Alanineaminotransferase as a marker of non-alcoholic fatty liver dis-ease in relation to type 2 diabetes mellitus and cardiovasculardisease [ J ]. Diabetes Metab Res Rev, 2006,22 ( 6 ):437-443.
6Hanley AJ, Wagenknecht LE, Festa A, et al.Alanine amin-otransferase (ALT) and directly measured insulin sensitivityin a multi-ethnic cohort : the Insulin Resistance Atheroscle-rosis Study [ J]. Diabetes Care, 2007, 30(7) : 1819-1827.
7Atar Al,Yilmaz OC,Akin K,et al. Association betweengamma-glutamyltransferase and coronary artery calcifi-cation[J]. Int J Cardiol, 2012,167(4) : 1264-1267.
9Annemans L, Spaepen E, Gaskin M, et al.Gout in the UKand Germany : prevalence, morbidities and management ingeneral practice 2000-2005 [ J] . Ann Rheum Dis,2008,67(7):960-966.
10Fraser A, Ebrahim S, Smith GD, et al. A comparison of as-sociations of alanine aminotransferase and gamma-glutamyl-transferase with fasting glucose,fasting insulin,and glycatedhemoglobin in women with and without diabetes [ J]. Hepa-tology, 2007,46(1) :158-165.
3R.shimoyama.T.Nakase.s.Kojima,Tanaka.K.Yamamori,c.Kaneko.K.Ishimaru a H.Ikeda,葛红卫.日本的献血者筛选:对献血前血红蛋白检测新标准的尝试[J].国外医学（输血及血液学分册）,2002,25(5):465-466. 被引量：4
